Business, energy, technology, markets and global industry news from Business News Today

dermatology clinical trials

Pharma & Biotech

Connect Biopharma advances rademikibart data as global competition grows in eczema biologics

Rademikibart Phase 3 eczema data will debut at AAD 2026. Discover what the trial could mean for IL-4 receptor biologics and global dermatology drug competition.

Read More
Pharma & Biotech

Menopause-specific hair loss enters the clinical spotlight after KilgourMD trial data

KilgourMD’s phase II data challenges how menopause-related hair loss is studied and treated. See what changes and what clinicians will watch next.

Read More
Pharma & Biotech

What Biofrontera’s Phase 3 results mean for non-facial actinic keratosis treatment strategies

Biofrontera reports positive Phase 3 Ameluz data outside the face and scalp. Find out how this could change actinic keratosis treatment.

Read More